Who from City of San Francisco area’s former high school standouts will be active on Saturday, June 13?
On Saturday, June 13, these former City of San Francisco area high school standouts will be in action.
More News
Surgery services in San Francisco see $6,619,911 in Medicaid payments for 2024
In 2024, Medicaid providers in San Francisco submitted $6,619,911 in claims categorized as Surgery services, representing a 150.5% rise from the prior year.
Who among former City of San Francisco area high school athletes will be active on Friday, May 22?
On Friday, May 22, these former City of San Francisco area high school stars will be competing.
City View Post Acute ranked No. 3 among largest nursing homes in San Francisco County for Q1 2026
City View Post Acute, awarded a five-star overall rating, ranked third in nursing home size in San Francisco County during the first quarter of 2026.
Academy of Art University awarded $4.45M in athletic financial aid for 2024
The U.S. Department of Education reports Academy of Art University in San Francisco distributed $4,457,415 in athletically related financial aid during 2024.
Who among former City of San Francisco area high school athletes will be active on Thursday, May 21?
These former City of San Francisco area high school standouts will be active on Thursday, May 21.
University of San Francisco distributes $9.6 million in athletic aid for 2024
The University of San Francisco in California allocated $9,619,419 in athletic financial aid for 2024, based on U.S. Department of Education figures.
Central Gardens Post Acute in San Francisco receives top CMS rating of 5 for Q1
Central Gardens Post Acute, owned by Providence Group, Inc. since Jan. 1, 2019, earned a top overall CMS rating of 5 in the first quarter of 2026.
UCSF Assistant Professor DiGiorgio on 340B: ‘340B has helped crush independent oncology practice’
UCSF Assistant Professor Anthony DiGiorgio said on May 13 that the federal 340B program disadvantages independent oncology practices by giving large hospital systems access to steeply discounted drugs.